Aims-To assess the validity and practicality of real time polymerase chain
reaction (PCR) for human papillomavirus (HPV) testing in combination with l
iquid based cytology samples for cervical screening.
Methods-Real time PCR using consensus (GP5+/6+) and type specific primers w
as developed to detect genital HPV types. This provides rapid, efficient am
plification followed by denaturation of the product and computer analysis o
f the kinetics data that are generated. Liquid based cytology samples were
obtained from attending routine cervical screening clinics. DNA was extract
ed from the residual cellular suspension after cytology using spin columns.
Results-Real time PCR successfully distinguished between HPV-16 and HPV-18
on the basis of amplification with consensus primers followed by DNA meltin
g temperature (T-m) analysis. Sensitivities of one to 10 copies of HPV-16 (
mean T-m = 79.4 degreesC; 2 SD, 0.8) and four to 40 copies of HPV-18 (mean
T-m = 80.4 degreesC; 2 SD, 0.4) were obtained. In a mixed population of SiH
a and HeLa cells containing known copy numbers of HPV-16 and HPV-18 genomes
, HPV-16 and HPV-18 products were clearly separated by T-m, analysis in mix
tures varying from equivalence to 1/1000. Together with detailed melt analy
sis, type specific primers from the same region of the L1 gene confirmed th
e differential ability of this system. The method was applied to 100 liquid
based cytology samples where HPV status using conventional GP5+/6+ PCR was
already known. There was 95% agreement between the methods, with 55 positi
ves detected by conventional PCR and 59 with real time FCR. The method was
then tested on 200 routine liquid based cytology samples. Approximately 10%
were positive by real time PCR, most of which were classified as HPV-16 by
detailed melt analysis. Thirteen (6.8%) HPV positives were identified in 1
89 samples showing no evidence of cervical cytological abnormality.
Conclusions-Real time PCR is a rapid, efficient method for the detection of
HPV with the separation of HPV-16 and HPV-18 on the basis of differential
T-m. Preliminary results suggest it could prove useful if HPV testing is ad
ded to cervical screening programmes.